280 related articles for article (PubMed ID: 221643)
1. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
Miller OV; Gorman RR
J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
[TBL] [Abstract][Full Text] [Related]
2. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
Ashby B
Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
[TBL] [Abstract][Full Text] [Related]
3. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
4. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
[TBL] [Abstract][Full Text] [Related]
5. Receptors for PGI2 and PGD2 on human platelets.
Siegl AM
Methods Enzymol; 1982; 86():179-92. PubMed ID: 6290840
[No Abstract] [Full Text] [Related]
6. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG
Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968
[TBL] [Abstract][Full Text] [Related]
7. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
Eggerman TL; Andersen NH; Robertson RP
J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
[TBL] [Abstract][Full Text] [Related]
9. On the multiplicity of platelet prostaglandin receptors. I. Evaluation of competitive antagonism by aggregometry.
Andersen NH; Eggerman TL; Harker LA; Wilson CH; De B
Prostaglandins; 1980 May; 19(5):711-35. PubMed ID: 6252573
[TBL] [Abstract][Full Text] [Related]
10. PGE1 but not PGI2 desensitizes the PGI2 receptor-adenylate cyclase complex in human foreskin fibroblasts.
Gorman RR; Hopkins NK
Adv Prostaglandin Thromboxane Res; 1980; 8():1717-21. PubMed ID: 6246790
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors.
Ashby B
Second Messengers Phosphoproteins; 1988; 12(1):45-57. PubMed ID: 2848122
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
13. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease.
Fitscha P; Kaliman J; Sinzinger H
Am J Hematol; 1985 May; 19(1):13-9. PubMed ID: 3885723
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
15. Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets.
Siegl AM; Daly JW
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(3):229-45. PubMed ID: 2991349
[TBL] [Abstract][Full Text] [Related]
16. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
[TBL] [Abstract][Full Text] [Related]
17. On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs.
Tynan SS; Andersen NH; Wills MT; Harker LA; Hanson SR
Prostaglandins; 1984 May; 27(5):683-96. PubMed ID: 6087417
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin releasing polymers - stability and efficacy.
McRea JC; Ebert CD; Kim SW
Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
Cooper B; Ahern D
J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813
[TBL] [Abstract][Full Text] [Related]
20. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
Jaschonek K; Renn W; Weisenberger H
Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
